WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King today announced that the U.S. Department of Health and Human Services (HHS) has awarded $200,000 to Cary Medical Center in Caribou as part of its Small Health Care Provider Quality Improvement Program.

WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King today announced that the Office of National Drug Control Policy (ONDCP) has awarded a total of $2,250,000 in grant funding to several Maine health coalitions to prevent youth substance abuse and foster drug-free communities in Maine. Of that funding, $375,000 will be allocated for three new grant awards while the remaining funding will be allocated to seven projects in the state that have previously received funding from ONDCP.

WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King today announced that two agencies within the U.S. Department of Health and Human Services (HHS) have awarded grant funding totaling $605,230 to the State of Maine to help fight the heroin and opioid abuse epidemic. Maine will receive $371,616 from the Substance Abuse and Mental Health Services Administration (SAMHSA) and $233,614 from the Centers for Disease Control and Prevention (CDC) to strengthen drug abuse prevention efforts and better track fatal and nonfatal opioid-involved overdoses in Maine.

WASHINGTON, D.C. – U.S.

WASHINGTON, D.C.—U.S.

Washington, D.C.—U.S. Senators Susan Collins and Claire McCaskill, the Chairman and Ranking Member of the Senate Special Committee on Aging, sent a letter to AstraZeneca seeking more information on the company’s position that generic competitors to Crestor® should be delayed from entering the market.

Washington, D.C.—With overwhelming bipartisan support, the U.S. Senate passed a comprehensive, evidence-based response to combat the heroin and opioid epidemic by a vote of 92-2. The Comprehensive Addiction and Recovery Act, or CARA, is cosponsored by U.S. Senator Susan Collins, a member of the Senate Health, Education, Labor, and Pensions Committee.  The CARA Conference Report contains two amendments authored by Senator Collins, as well as a number of provisions for which she advocated.

WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King announced today that the Maine Department of Health and Human Services (DHHS) will receive $176,049 in federal funding from the U.S. Centers for Disease Control and Prevention (CDC) to bolster public health system preparedness and response capabilities to protect Americans from the Zika virus.

Washington, D.C.—U.S. Senator Susan Collins, the Co-Chair of the Congressional Task Force on Alzheimer’s Disease and a senior member of the Senate Appropriations Committee, announced today that the Committee approved $1.391 billion for Alzheimer’s research at the National Institutes of Health, an increase of $400 million. 

WASHINGTON, D.C.—As part of a multifaceted approach to address our nation’s opioid abuse and heroin public health crisis, U.S. Senators Susan Collins (R-Maine) and Claire McCaskill (D-Missouri), the Chairman and Ranking Member of the Senate Aging Committee, have written to five companies regarding their efforts to preserve the accessibility of the opioid reversal drug naloxone. 

Washington, D.C.—U.S. Senator Susan Collins, a senior member of the Senate Appropriations Commerce, Justice, Science, and Related Agencies Subcommittee, announced today that the Senate Appropriations Committee has approved $132 million to combat the heroin and opioid abuse crisis.  The legislation was unanimously approved by the Committee and will now be considered by the full Senate.

Washington, D.C.—U.S. Senators Susan Collins and Angus King announced that the Mount Desert Island Biological Laboratory has been awarded $249,000 by the National Institute of Neurological Disorders and Stroke.  The grant will allow researchers to study a possible cause of chemotherapy-induced peripheral neuropathy (CIPN).

Click HERE to watch Senator Collins’ floor statement

Washington, D.C.—U.S. Senator Susan Collins spoke from the Senate floor today to urge her colleagues to support funding to address the emerging and evolving Zika virus, which poses a particular threat to pregnant women and can cause serious birth defects. 

“Since I founded the Senate Diabetes Caucus in 1997, funding for diabetes research has more than tripled,” said Senator Collins.  “The 2016 omnibus spending bill passed late last year continues this progress with an overall $2 billion increase for the National Institutes of Health, the largest since 2003, but there is still much work to be done.  I have called on my colleagues to maintain our strong commitment to diabetes research in the 2017 spending bill, and Senator Shaheen and I are determined to require Medicare to cover Continuous Glucose Monitors, just as many private insurance companies already do.  Today’s investments will yield cures and therapies for patients tomorrow.”